These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 14632421)

  • 1. Comparative molecular surface analysis (CoMSA) for modeling dye-fiber affinities of the azo and anthraquinone dyes.
    Polanski J; Gieleciak R; Wyszomirski M
    J Chem Inf Comput Sci; 2003; 43(6):1754-62. PubMed ID: 14632421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilinear regression and comparative molecular field analysis (CoMFA) of azo dye-fiber affinities. 2. Inclusion of solution-phase molecular orbital descriptors.
    Schüürmann G; Funar-Timofei S
    J Chem Inf Comput Sci; 2003; 43(5):1502-12. PubMed ID: 14502484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRID formalism for the comparative molecular surface analysis: application to the CoMFA benchmark steroids, azo dyes, and HEPT derivatives.
    Polanski J; Gieleciak R; Magdziarz T; Bak A
    J Chem Inf Comput Sci; 2004; 44(4):1423-35. PubMed ID: 15272850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steric and electrostatic effects in dye-cellulose interactions by the MTD and CoMFA approaches.
    Timofeir S; Kurunczi L; Schmidt W; Simon Z
    SAR QSAR Environ Res; 2002 Mar; 13(2):219-26. PubMed ID: 12071650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling robust QSAR. 1. Coding molecules in 3D-QSAR--from a point to surface sectors and molecular volumes.
    Gieleciak R; Magdziarz T; Bak A; Polanski J
    J Chem Inf Model; 2005; 45(5):1447-55. PubMed ID: 16180922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling robust QSAR 3: SOM-4D-QSAR with iterative variable elimination IVE-PLS: application to steroid, azo dye, and benzoic acid series.
    Bak A; Polanski J
    J Chem Inf Model; 2007; 47(4):1469-80. PubMed ID: 17567123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling robust QSAR. 2. iterative variable elimination schemes for CoMSA: application for modeling benzoic acid pKa values.
    Gieleciak R; Polanski J
    J Chem Inf Model; 2007; 47(2):547-56. PubMed ID: 17381172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative molecular field analysis (CoMFA) of anionic azo dye-fiber affinities I: gas-phase molecular orbital descriptors.
    Funar-Timofei S; Schüürmann G
    J Chem Inf Comput Sci; 2002; 42(4):788-95. PubMed ID: 12132879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug design using comparative molecular surface analysis.
    Polanski J
    Expert Opin Drug Discov; 2006 Dec; 1(7):693-707. PubMed ID: 23495994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment.
    Yuan H; Kozikowski AP; Petukhov PA
    J Med Chem; 2004 Dec; 47(25):6137-43. PubMed ID: 15566285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
    Chen JZ; Han XW; Liu Q; Makriyannis A; Wang J; Xie XQ
    J Med Chem; 2006 Jan; 49(2):625-36. PubMed ID: 16420048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore and docking-based combined in-silico study of KDR inhibitors.
    Pasha FA; Muddassar M; Neaz MM; Cho SJ
    J Mol Graph Model; 2009 Aug; 28(1):54-61. PubMed ID: 19447057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling steric and electronic effects in 3D- and 4D-QSAR schemes: predicting benzoic pK(a) values and steroid CBG binding affinities.
    Polanski J; Bak A
    J Chem Inf Comput Sci; 2003; 43(6):2081-92. PubMed ID: 14632460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
    Chaudhaery SS; Roy KK; Saxena AK
    J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR CoMFA/CoMSIA studies on Urokinase plasminogen activator (uPA) inhibitors: a strategic design in novel anticancer agents.
    Bhongade BA; Gadad AK
    Bioorg Med Chem; 2004 May; 12(10):2797-805. PubMed ID: 15110861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H; Li H; Ma Q
    J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore-based 3D-QSAR of HIF-1 inhibitors.
    Chung JY; Pasha FA; Cho SJ; Won M; Lee JJ; Lee K
    Arch Pharm Res; 2009 Mar; 32(3):317-23. PubMed ID: 19387572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.